Question
Name the source used to produce hepatitis-B vaccine using rDNA technology.

Answer

Recombinant DNA technology has allowed the production of antigenic polypeptides of pathogen in bacteria or yeast. Vaccines produced using this approach allow large scale production and hence, greater availability for immunisation, e.g. source of hepatitis-B vaccine is yeast.

Need a full question paper?

Generate a complete, print-ready paper with questions like this in minutes — across 16+ boards, with answer keys.

Start Generating Free